Status:
COMPLETED
Psychosocial Pain Management to Improve Opioid Use Disorder Treatment Outcomes
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
US Department of Veterans Affairs
Conditions:
Opioid-use Disorder
Medication Assisted Treatment
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research study is to look at the effect of programs aimed at helping people manage chronic pain and medication treatment. The program sessions focus on educational information and ...
Eligibility Criteria
Inclusion
- having a diagnosis of an opioid use disorders (OUD) within the past 12 months;
- started buprenorphine (the term we use to refer to all buprenorphine products including buprenorphine/naloxone) treatment within the past 6 months
- at least moderate or greater self-reported pain on average over the past 3 months;
- regular and consistent access to a telephone and willingness to use the phone for study sessions.
Exclusion
- buprenorphine medication prescribed in the form of a monthly injection and/or a transdermal patch
- self-reported pregnancy at the time of study enrollment
- currently living outside of the United States
Key Trial Info
Start Date :
August 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 19 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04433975
Start Date
August 14 2020
End Date
January 19 2025
Last Update
July 9 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Veterans Affair Ann Arbor Healthcare System
Ann Arbor, Michigan, United States, 48105
2
Michigan Medicine
Ann Arbor, Michigan, United States, 48109